A Randomized, Double-Blind, Four-Arm Study Comparing Combination Nucleoside, Alternating Nucleoside, and Triple-Drug Therapy for the Treatment of Advanced HIV Disease (CD4 <= 50/mm3)

NCT00000781 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

1292

Enrollment

NIH

Sponsor class

Conditions

HIV Infections

Interventions

DRUG: Nevirapine
DRUG: Zidovudine
DRUG: Zalcitabine
DRUG: Didanosine

Sponsor

National Institute of Allergy and Infectious Diseases (NIAID)

Collaborators

[object Object]
[object Object]